Pierluigi Tricoci Selected Research

Pierluigi Tricoci Research Topics

Disease

56	Acute Coronary Syndrome 01/2022 - 09/2002
41	Myocardial Infarction 04/2024 - 10/2005
31	Hemorrhage 01/2020 - 09/2002
19	Stroke (Strokes) 04/2024 - 04/2006
8	Ischemia 03/2017 - 02/2011
5	Coronary Artery Disease (Coronary Atherosclerosis) 04/2024 - 03/2007
5	Thrombosis (Thrombus) 03/2024 - 05/2007
4	ST Elevation Myocardial Infarction 01/2017 - 05/2007
4	Unstable Angina 01/2017 - 04/2006
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 08/2016
2	Atherosclerotic Plaque (Atheroma) 01/2022 - 01/2021
2	Peripheral Arterial Disease 01/2021 - 10/2014
2	Acute Kidney Injury (Acute Renal Failure) 01/2019 - 08/2016
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2018 - 01/2012
2	Atherosclerosis 05/2018 - 08/2015
2	Transient Ischemic Attack 05/2017 - 06/2015
2	Atrial Fibrillation 05/2017 - 10/2013
1	Hypersensitivity (Allergy) 04/2024
1	Body Weight (Weight, Body) 01/2021
1	Chronic Renal Insufficiency 01/2019
1	Hemorrhagic Stroke 12/2018
1	Injection Site Reaction 11/2018
1	Gout 05/2017
1	Non-ST Elevated Myocardial Infarction 01/2017
1	Peptic Ulcer (Peptic Ulcers) 01/2017
1	Albuminuria 08/2016
1	Diabetes Mellitus 03/2014
1	Death (Near-Death Experience) 10/2013
1	Infarction (Infarctions) 06/2013
1	Renal Insufficiency (Renal Failure) 11/2011
1	Coronary Disease (Coronary Heart Disease) 07/2009
1	Inflammation (Inflammations) 03/2007
1	Hypercholesterolemia 04/2006

Drug/Important Bio-Agent (IBA)

22	vorapaxarIBA 12/2018 - 10/2010
20	Thrombin Receptors (Thrombin Receptor)IBA 01/2020 - 10/2010
11	Glycoproteins (Glycoprotein)IBA 01/2018 - 10/2006
10	CSL112IBA 04/2024 - 08/2015
10	Apolipoprotein A-I (Apolipoprotein A1)IBA 04/2024 - 08/2015
7	Clopidogrel (Plavix)FDA Link 01/2015 - 10/2005
7	Eptifibatide (Integrilin)FDA Link 10/2013 - 05/2007
6	CholesterolIBA 04/2024 - 10/2016
6	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2017 - 04/2006
5	alirocumabIBA 01/2019 - 11/2014
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 11/2014
5	Peptide Hydrolases (Proteases)FDA Link 12/2018 - 01/2012
4	CreatinineIBA 01/2019 - 11/2011
4	Platelet Membrane Glycoprotein IIbIBA 05/2015 - 05/2007
3	HDL LipoproteinsIBA 04/2024 - 08/2015
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 07/2013
3	oxidized low density lipoproteinIBA 01/2019 - 11/2014
3	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 05/2018 - 10/2013
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 12/2015 - 10/2010
3	PAR-1 ReceptorIBA 12/2015 - 07/2014
3	TroponinIBA 06/2015 - 07/2013
3	Enoxaparin (Lovenox)FDA LinkGeneric 07/2013 - 09/2002
2	apixabanIBA 01/2020 - 01/2016
2	human APOA1 proteinIBA 01/2019 - 05/2018
2	LDL CholesterolIBA 11/2018 - 11/2014
2	Monoclonal AntibodiesIBA 11/2018 - 11/2014
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 06/2015 - 09/2002
1	Proteins (Proteins, Gene)FDA Link 04/2024
1	LipidsIBA 01/2022
1	MDCO-216IBA 01/2022
1	ApoproteinsIBA 01/2022
1	CER-001IBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2019
1	Lipoproteins (Lipoprotein)IBA 01/2019
1	ApolipoproteinsIBA 11/2018
1	HDL CholesterolIBA 11/2018
1	LDL Lipoproteins (beta Lipoproteins)IBA 11/2018
1	Proprotein Convertase 9IBA 11/2018
1	protease-activated receptor 4IBA 01/2018
1	Uric Acid (Urate)IBA 05/2017
1	thienopyridineIBA 03/2017
1	omega-Chloroacetophenone (Mace)IBA 08/2016
1	AnticoagulantsIBA 01/2015
1	Prasugrel Hydrochloride FDA Link 01/2015
1	Thrombin FDA Link 01/2015
1	TicagrelorIBA 01/2015
1	MetalsIBA 09/2014
1	cangrelorIBA 09/2013
1	trans-crotonin (CTN)IBA 07/2013
1	Proteinase-Activated ReceptorsIBA 06/2013
1	MB Form Creatine KinaseIBA 12/2012
1	E 5555IBA 10/2010
1	Adenosine Diphosphate (ADP)IBA 07/2009
1	Tissue Plasminogen Activator (Alteplase)FDA Link 12/2007
1	Streptokinase FDA Link 12/2007
1	Matrix Metalloproteinases (MMPs)IBA 03/2007

Therapy/Procedure

20	Therapeutics 01/2022 - 10/2005
17	Percutaneous Coronary Intervention 01/2020 - 10/2006
8	Patient Readmission 03/2017 - 01/2012
7	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2019 - 04/2006
5	Stents 03/2024 - 07/2009
2	Drug Therapy (Chemotherapy) 01/2021 - 10/2016
1	Secondary Prevention 12/2018
1	Injections 11/2014
1	Drug-Eluting Stents 09/2014
1	Dual Anti-Platelet Therapy 06/2013
1	Blood Transfusion (Blood Transfusions) 12/2007